Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in BPTH — Bio-Path Holdings, Inc.

CIK 1214717 BOSTON, MA
Back to BPTH Full portfolio

Position in BPTH

as of Dec 31, 2024 · filed Feb 12, 2025
Position Value
$14,439
+$2,065 QoQ
Shares Held
12,448
-8.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BPTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in BPTH

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2024-12-31 $14,439 12,448
2024-09-30 $12,374 13,598
2024-06-30 $21,732 10,866
2023-12-31 $50,801 110,438
2023-09-30 $34,946 94,449
2023-06-30 $119,915 67,368
2023-03-31 $93,641 67,368
2022-12-31 $101,725 67,368
2022-09-30 $215,385 67,519
2022-06-30 $261,298 67,519
2022-03-31 $252,606 65,783
2021-12-31 $248,001 65,783
2021-09-30 $337,466 65,783
2021-06-30 $435,904 65,353
2021-03-31 $397,261 56,590
2020-12-31 $119,661 34,189
2020-09-30 $87,526 20,643
2020-06-30 $104,247 20,643
2020-03-31 $92,893 20,643